Last reviewed · How we verify
0.9% Bacteriostatic Local Anesthetic Injection — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
0.9% Bacteriostatic Local Anesthetic Injection (0.9% Bacteriostatic Local Anesthetic Injection) — University of California, San Francisco.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 0.9% Bacteriostatic Local Anesthetic Injection TARGET | 0.9% Bacteriostatic Local Anesthetic Injection | University of California, San Francisco | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 0.9% Bacteriostatic Local Anesthetic Injection CI watch — RSS
- 0.9% Bacteriostatic Local Anesthetic Injection CI watch — Atom
- 0.9% Bacteriostatic Local Anesthetic Injection CI watch — JSON
- 0.9% Bacteriostatic Local Anesthetic Injection alone — RSS
Cite this brief
Drug Landscape (2026). 0.9% Bacteriostatic Local Anesthetic Injection — Competitive Intelligence Brief. https://druglandscape.com/ci/0-9-bacteriostatic-local-anesthetic-injection. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab